Muhammad Wasif Saif

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-10

• An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development

  Expert Opinion on Investigational Drugs · 2025-12-02 · 1 citations

• Staged approach to overcome hyperbilirubinemia: tailored chemotherapy in liver metastases-a case report

  Journal of Gastrointestinal Oncology · 2025-12-01

• Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinomaPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-11-25

• An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors

  International Journal of Molecular Sciences · 2025-11-16 · 1 citations

• Respiratory syncytial virus (RSV) infection in adults with blood cancer: An England-wide population study

  Blood · 2025-11-03

• Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer

  Journal of Clinical Oncology · 2025-09-24 · 1 citations

• XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

  Translational Lung Cancer Research · 2025-08-01 · 1 citations

• Hypertension management in multimorbid patients: Insights from internal medicine

  International Journal of Advanced Community Medicine · 2025-07-01

• TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients

  International Journal of Molecular Sciences · 2025-07-01 · 5 citations

• Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Abstract 7213: Targeting XPO1 to enhance the durability of response of MRTX1133 in pancreatic ductal adenocarcinoma

  Cancer Research · 2025-04-21

• Abstract 6909: Exportin 1 as a novel therapeutic target in gastroenteropancreatic neuroendocrine tumors

  Cancer Research · 2025-04-21

• Abstract 6876: A novel PCNA inhibitor AOH1996 demonstrates pre-clinical efficacy in pancreatic ductal adenocarcinoma models

  Cancer Research · 2025-04-21 · 2 citations

• Ptcy Overcomes HLA Mismatch in Unrelated Donor Transplant for Acute Lymphoblastic Leukemia: A Study from the ALWP of the EBMT

  Blood · 2024-11-05 · 1 citations

• RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth

  Cancer Letters · 2024-09-24 · 6 citations

• Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults

  JACC CardioOncology · 2024-08-01 · 16 citations